Neil E. Stahl - 10 Nov 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research and Development
Signature
/s/**Neil Stahl
Issuer symbol
REGN
Transactions as of
10 Nov 2023
Net transactions value
$0
Form type
4
Filing time
14 Nov 2023, 16:03:30 UTC
Previous filing
23 Aug 2023
Next filing
12 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -400 -0.75% $0.000000 52,700 10 Nov 2023 Direct
holding REGN Common Stock 5,834 10 Nov 2023 By 401(k) Plan
holding REGN Common Stock 4,605 10 Nov 2023 by Spouse as Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.